|
× |
 |
Efficacy of a Behavioral Activation Teletherapy Intervention to Treat Depression and Anxiety in Primary Care VitalSign6 Program PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Effects of Metrifonate on the Cognitive, Behavioral, and Functional Performance of Alzheimer's Disease Patients PDF |
$40.00 |
|
$40.00 |
|
× |
|
Reboxetine, a Unique Selective NRI, Prevents Relapse and Recurrence in Long-Term Treatment of Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Medical Comorbidity Among Youth Diagnosed With Bipolar Disorder in the United States PDF |
$40.00 |
|
$40.00 |
|
× |
|
Efficacy of Venlafaxine Extended Release in Patients With Major Depressive Disorder and Comorbid Generalized Anxiety Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Chromium Potentiation of Antidepressant Pharmacotherapy for Dysthymic Disorder in 5 Patients PDF |
$40.00 |
|
$40.00 |
|
× |
|
Risperidone Added to Clozapine: Impact on Serum Prolactin Levels PDF |
$40.00 |
|
$40.00 |
|
|
